ArticleEcancermedicalscience2025
Predictors of late diagnosis of prostate cancer among men of African ancestry receiving care at urology clinic, Federal Medical Centre, Abeokuta.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Burden, clinical characteristics, and management patterns of prostate cancer in Nigeria: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Cultural Factors Influencing Prostate Cancer Screening Uptake in Urban Ogun State, Nigeria: A Review of Evidence.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
- Prostate Cancer Management in Nigeria: A mini-review of up-to-date treatment options.Nigerian medical journal : journal of the Nigeria Medical AssociationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer (CaP) is a significant global health challenge, ranking as a leading cause of cancer mortality among men, particularly in Sub-Saharan Africa. In Nigeria, CaP accounts for 37.5% of new cancer cases and a high mortality rate, largely attributed to late-stage diagnoses. While early detection through screening methods such as digital rectal examination (DRE) and prostate-specific antigen (PSA) testing can improve survival outcomes, barriers persist, especially among men of African ancestry who are at higher risk from age 40. This study explores the reasons behind delayed screening and late diagnosis in Sub-Saharan Africa, identifying barriers using the health belief model as a framework; hence, the research explored key constructs: perceived susceptibility, severity, benefits, barriers (cues to action) and self-efficacy. This cross-sectional study specifically examines these predictors among adult males attending a urology clinic in Abeokuta, Nigeria. A simple random sampling technique was used to recruit 128 study participants. The study found that, despite empirical evidence highlighting increased susceptibility to CaP from the age of 40, most participants perceived themselves as not at risk, indicating a significant lack of awareness. This low perceived susceptibility negatively impacts health-seeking behaviours, including early screening. Participants generally acknowledged the severity of CaP, which should ideally motivate preventive actions. However, many found decision-making about screening and undertaking annual DRE or PSA tests challenging, reflecting low self-efficacy. While participants recognised the benefits of preventive measures, barriers such as embarrassment, fear of pain and lack of physician recommendations were reported. Notably, the absence of screening recommendations by healthcare providers emerged as a significant gap, despite guidelines advocating early screening for men of African ancestry. These findings underscore the need for targeted interventions to raise awareness, enhance self-efficacy, address procedural concerns and encourage proactive physician involvement in recommending screenings to mitigate the high prevalence of late-stage diagnoses of CaP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.